Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Long‐term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus–related cirrhosis
2015
Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS)
2011
Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B
2015
Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection
2012
Reversion of disease manifestations after HCV eradication
2016
Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
2012
TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON
2016
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
2014
The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma
2015
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis
2009
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
2016
Burden of liver diseases in the world
2018 Standout
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
2013
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis
2009
Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma
2015
Sox4 Is a Master Regulator of Epithelial-Mesenchymal Transition by Controlling Ezh2 Expression and Epigenetic Reprogramming
2013
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
2008
Hepatitis B virus DNA levels and outcomes in chronic hepatitis B # †
2009
Albumin–drug interaction and its clinical implication
2013 Standout
Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance
2010
Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
2013
Hepatitis B virus infection
2009 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Factors predictive of risk for complications in patients with oesophageal foreign bodies
2011
Epidemiology of sarcopenia and insight into possible therapeutic targets
2017
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Quantitative analysis of plasma HBV DNA for early evaluation of the response to transcatheter arterial embolization for HBV-related hepatocellular carcinoma
2005
New Technologies in Clinical Ultrasound
2013
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Non-alcoholic fatty liver disease
2021 Standout
Hepatitis B reactivation after chemotherapy: two decades of clinical research
2008
Chronic hepatitis B
2007 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Sarcopenia
2019 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Global burden of liver disease: 2023 update
2023 Standout
Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment
2016
Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes
2008
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
2014
A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization
2006
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
2015
Lower Incidence of Hepatocellular Carcinoma and Cirrhosis in Hepatitis C Patients with Sustained Virological Response by Pegylated Interferon and Ribavirin
2014
Hepatocellular Carcinoma
2011 Standout
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy
2010
Hepatocellular carcinoma
2022 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Serum Aminotransferase Flares in Pregnant and Postpartum Women With Current or Prior Treatment for Chronic Hepatitis B
2017
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus‐related decompensated cirrhosis
2011
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
<p>Taiwan’s National Health Insurance Research Database: past and future</p>
2019 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience
2020
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy
2006
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Tailoring the volatility and stability of oligopeptides
2017 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
NAFLD and Chronic Kidney Disease
2016
Enhancing the Migration Ability of Mesenchymal Stromal Cells by Targeting the SDF-1/CXCR4 Axis
2013
Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
2011
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy
2011
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis‐4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta‐analysis
2014
Removal of foreign bodies in the upper gastrointestinal tract in adults: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
2016 Standout
Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
2013
Works of Jin Mo Yang being referenced
Risk Factors Predicting the Development of Complication after Foreign Body Ingestion
2009
Cell death is induced by ciglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, independently of PPARγ in human glioma cells
2011
Evolution of viral load and changes of polymerase and precore/core promoter sequences in lamivudine‐resistant hepatitis B virus during adefovir therapy
2007
Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma
2004
A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
2014
SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro
2010
Heavy Alcohol Consumption with Alcoholic Liver Disease Accelerates Sarcopenia in Elderly Korean Males: The Korean National Health and Nutrition Examination Survey 2008-2010
2016
Long-Term Outcome of High-Intensity Focused Ultrasound in Advanced Pancreatic Cancer
2011
Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma
2012
The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization
2007
Non-Invasive Index for Predicting Significant Liver Fibrosis: Comparison of Diagnostic Performances in Patients with Chronic Hepatitis B and C
2010
A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients
2014
Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation – a pilot study
2005
Comparison of Surrogate Serum Markers and Transient Elastography (Fibroscan) for Assessing Cirrhosis in Patients with Chronic Viral Hepatitis
2010
Outcome after discontinuing antiviral agents during pregnancy in women infected with hepatitis B virus
2012
Diagnostic value of multiple biomarker panel for prediction of significant fibrosis in chronic hepatitis C
2011
Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis
2005
Efficacy and Tolerability of Peginterferon Alpha Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Korea: A Multi-Center, Retrospective Observational Study
2012
Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population
2005
Noninvasive markers to diagnose cirrhosis in patients with HBeAg positive chronic hepatitis: Do new biomarkers improve the accuracy?
2010
p53Genetic Polymorphism of Gastric cancer in Korea
2006
Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
2013
Clinical Outcomes of Delayed Clearance of Serum HBsAg in Patients with Chronic HBV Infection
2007
Effect ofEx VivoCulture Conditions on Immunosuppression by Human Mesenchymal Stem Cells
2013